A veteran B2B tech investor utilizing a "test local, go global" philosophy to scale enterprise software and hardware startups across international markets.
About 212 Ventures
212 Ventures, sometimes branded simply as 212 or 212.vc, is a veteran B2B-focused VC headquartered in Istanbul that has built a reputation for backing enterprise software and hardware startups with a test-local-go-global philosophy. The firm invests at seed, Series A, and Series B with checks in the $1M to $5M range, and its healthcare interest is concentrated in health IT and digital health software with credible enterprise GTM, including AI-native applications. The pattern recognition is enterprise-first: 212 wants to see B2B sales motions, defensible product moats, and founders who can articulate a path from a Turkish or regional beachhead market into international expansion, particularly into Europe and the Gulf. The geographic story is the firm’s signature. 212 has cultivated a network that spans Istanbul, London, Dubai, and Riyadh, and the value-add for founders is meaningful when the company needs to internationalize beyond Turkey, where the Lira and the local enterprise market alone cannot support a venture-scale outcome. The right founder profile is a Turkish or MENA-headquartered B2B software founder with technical depth, early enterprise traction, and a credible international expansion thesis, ideally with a product where the regional cost structure creates a structural advantage versus US or European incumbents. The wrong fit is a consumer brand, a hardware-heavy medtech device, or a research-stage biotech; 212 is fundamentally an enterprise software investor. The right entry path is through Istanbul founder networks, through participation in the Endeavor Turkey ecosystem, through alumni of companies like Insider, Iyzico, and Getir, or through warm introductions from regional co-investors. The 212 team is reachable but selective, and the diligence process is rigorous on commercial metrics. When pitching, lead with the enterprise sales motion, ACV, sales cycle length, retention, and the international expansion playbook; AI capability is welcome but is not a substitute for enterprise GTM proof points. Caveats: 212’s healthcare-specific operating expertise is lighter than its general enterprise software depth, so founders should bring in healthcare-specialist co-investors as the company scales. Use 212 when you need a regionally credible enterprise VC who can help you punch above Turkey’s weight class internationally.
Founder reviews
Other portfolio companies
Companies in 212 Ventures's portfolio not currently in our directory.
- Freshworks
- Iyzi Payments
- PayU
Pitch / review this investor
Have you raised from 212 Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).